StockData

Cytek Biosciences vs Kewaunee Scientific

CTKB and KEQU side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CTKB and KEQU compare

Cytek Biosciences is the larger company, worth 7.5 times as much as Kewaunee Scientific ($741M against $98.5M).

Cytek Biosciences grew revenue faster over the last twelve months (5.4% versus 5.3% for Kewaunee Scientific).

Kewaunee Scientific scores higher on the StockData Score (14 against 7 for Cytek Biosciences), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCTKBKEQU
Size and price
Market cap$741M$98.5M
Share price$5.70$34.01
Change, 1 year3.6%−15.9%
Change, 5 years−70.0%162%
Beta (5Y)0.290.83
Employees702–
StockData Score
Total score714 (better)
Valuation score25 (better)
Growth score01 (better)
Performance score04 (better)
Health score5 (better)4
Dividend score00
Valuation
P/E–12.3×
P/S3.6×0.4× (better)
P/B2.3×1.3× (better)
EV/EBITDA–5.2×
P/FCF–9.1×
PEG–0.09
FCF yield−1.6%11.0% (better)
Fair value$6.27$75.70
Margin of safety9.0%55.1% (better)
Growth
Revenue growth (TTM)5.4% (better)5.3%
Revenue growth, 5Y average209% (better)13.8%
Net income growth (TTM)–−33.1%
EPS growth (TTM)–−33.2%
Profitability
Gross margin53.2% (better)28.6%
Operating margin−21.6%5.4% (better)
Net margin–3.0%
FCF margin−5.8%3.9% (better)
Return on equity–11.6%
Return on invested capital−12.8%13.1% (better)
Financial health
Debt / equity0.000.25 (better)
Net debt / EBITDA–0.50
Interest coverage−143.1×4.4× (better)
Current ratio4.48 (better)2.20
Altman Z-score4.06 (better)3.41
Piotroski F-score34 (better)
Dividends and buybacks
Buyback yield−0.01%–
Shareholder yield−0.01%0.00% (better)
Ownership
Held by institutions62.7%41.4%
Held by insiders10.6%16.1%
Insider net buying, 12 months–−$293K
Superinvestors holding1–
Short interest, % of float3.5%1.6%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.